NCT06385288 Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
| NCT ID | NCT06385288 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Soft Tissue Sarcoma Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2021-07-21 |
| Primary Completion | 2026-07-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2021-07-21 with a primary completion date of 2026-07-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
"Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.
Eligibility Criteria
Inclusion Criteria: * Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling * Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy) * Planned resection of a department of the CWS * Age \> 18 years * Ability to consent * Additionally for imaging study: Treatment on the combined MR hyperthermia device Exclusion Criteria: * Age \< 18 years * Poor understanding (language etc.) * Lack of reconnaissance ability
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06385288 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Soft Tissue Sarcoma Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06385288 currently recruiting?
Yes, NCT06385288 is actively recruiting participants. Contact the research team at franziska.eckert@med.uni-tuebingen.de for enrollment information.
Where is the NCT06385288 trial being conducted?
This trial is being conducted at Tübingen, Germany.
Who is sponsoring the NCT06385288 clinical trial?
NCT06385288 is sponsored by University Hospital Tuebingen. The trial plans to enroll 30 participants.